{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T11:07:54Z","timestamp":1779966474364,"version":"3.53.1"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T00:00:00Z","timestamp":1638489600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["NET-2016-02361805"],"award-info":[{"award-number":["NET-2016-02361805"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.biopha.2021.112505","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T01:11:43Z","timestamp":1638839503000},"page":"112505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Is there a rational basis for cannabinoids research and development in ocular pain therapy? A systematic review of preclinical evidence"],"prefix":"10.1016","volume":"146","author":[{"given":"D.","family":"Scuteri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Rombol\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Hamamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Sakurada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sakurada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Guida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Boccella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Maione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Gallo Afflitto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Nucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Tonin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Bagetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.T.","family":"Corasaniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.112505_bib1","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.3390\/jcm9124036","article-title":"CannabinEYEds: the endocannabinoid system as a regulator of the ocular surface nociception, inflammatory response, neovascularization and wound healing","volume":"9","author":"Aiello","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.biopha.2021.112505_bib2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s40135-015-0073-9","article-title":"What causes eye pain?","volume":"3","author":"Belmonte","year":"2015","journal-title":"Curr. Ophthalmol. Rep."},{"key":"10.1016\/j.biopha.2021.112505_bib3","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0304-3959(02)00271-3","article-title":"Topical cannabinoid agonist, WIN55,212-2, reduces cornea-evoked trigeminal brainstem activity in the rat","volume":"99","author":"Bereiter","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2021.112505_bib4","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1002\/cne.23333","article-title":"M\u00fcller cells express the cannabinoid CB2 receptor in the vervet monkey retina","volume":"521","author":"Bouskila","year":"2013","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.biopha.2021.112505_bib5","doi-asserted-by":"crossref","first-page":"15210","DOI":"10.1038\/s41598-020-72295-x","article-title":"Ocular surface inflammation induces de novo expression of substance P in the trigeminal primary afferents with large cell bodies","volume":"10","author":"Byun","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2021.112505_bib6","doi-asserted-by":"crossref","DOI":"10.1167\/tvst.8.2.6","article-title":"Latent sensitization in a mouse model of ocular neuropathic pain","volume":"8","author":"Cho","year":"2019","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.biopha.2021.112505_bib7","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.phrs.2010.12.019","article-title":"N-palmitoyl-vanillamide (palvanil) is a non-pungent analogue of capsaicin with stronger desensitizing capability against the TRPV1 receptor and anti-hyperalgesic activity","volume":"63","author":"De Petrocellis","year":"2011","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2021.112505_bib8","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.ophtha.2017.08.004","article-title":"Neuropathic corneal pain: approaches for management","volume":"124","author":"Dieckmann","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.biopha.2021.112505_bib9","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s12974-019-1656-4","article-title":"Chronic dry eye induced corneal hypersensitivity, neuroinflammatory responses, and synaptic plasticity in the mouse trigeminal brainstem","volume":"16","author":"Fakih","year":"2019","journal-title":"J. Neuroinflamm."},{"issue":"20","key":"10.1016\/j.biopha.2021.112505_bib10","doi-asserted-by":"crossref","first-page":"11212","DOI":"10.3390\/ijms222011212","article-title":"New pyridone-based derivatives as cannabinoid receptor type 2 agonists","volume":"22","author":"Fa\u00fandez-Parraguez","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2021.112505_bib11","article-title":"Effects of topical low-dose preservative-free hydrocortisone on intraocular pressure in patients affected by ocular surface disease with and without glaucoma","author":"Filippelli","year":"2021","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol.\u2009=\u2009Albrecht Von Graefes Arch. fur Klin. und Exp. Ophthalmol."},{"issue":"4","key":"10.1016\/j.biopha.2021.112505_bib12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s41669-019-0138-z","article-title":"Cenegermin for treating neurotrophic keratitis: an evidence review group perspective of a NICE single technology appraisal","volume":"3","author":"Fleeman","year":"2019","journal-title":"PharmacoEcon Open"},{"issue":"4","key":"10.1016\/j.biopha.2021.112505_bib13","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/ICU.0b013e32833a8c15","article-title":"Impact of dry eye disease and treatment on quality of life","volume":"21","author":"Friedman","year":"2010","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.biopha.2021.112505_bib14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/eye.2014.263","article-title":"Neuropathic ocular pain: an important yet underevaluated feature of dry eye","volume":"29","author":"Galor","year":"2015","journal-title":"Eye"},{"key":"10.1016\/j.biopha.2021.112505_bib15","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/archopht.1978.03910050373015","article-title":"Osmolarity of tear microvolumes in keratoconjunctivitis sicca","volume":"96","author":"Gilbard","year":"1978","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.biopha.2021.112505_bib16","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1093\/pm\/pnv058","article-title":"Successful management of corneal neuropathic pain with intrathecal targeted drug delivery","volume":"17","author":"Hayek","year":"2016","journal-title":"Pain Med."},{"key":"10.1016\/j.biopha.2021.112505_bib17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE\u2019s risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.biopha.2021.112505_bib18","first-page":"142","article-title":"Eye and periocular skin involvement in herpes zoster infection","volume":"4","author":"Kalogeropoulos","year":"2015","journal-title":"Med. Hypothesis Discov. Innov. Ophthalmol. J."},{"key":"10.1016\/j.biopha.2021.112505_bib19","doi-asserted-by":"crossref","DOI":"10.1042\/NS20170144","article-title":"Potential for endocannabinoid system modulation in ocular pain and inflammation: filling the gaps in current pharmacological options","volume":"2","author":"Lafreniere","year":"2018","journal-title":"Neuronal Signal."},{"key":"10.1016\/j.biopha.2021.112505_bib20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.nbd.2015.12.017","article-title":"Ocular inflammation induces trigeminal pain, peripheral and central neuroinflammatory mechanisms","volume":"88","author":"Launay","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biopha.2021.112505_bib21","first-page":"1","article-title":"Beyond dry eye: how co-morbidities influence disease phenotype in dry eye disease","author":"Lee","year":"2021","journal-title":"Clin. Exp. Optom."},{"key":"10.1016\/j.biopha.2021.112505_bib22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jtos.2020.10.004","article-title":"Pain sensitivity and autonomic nervous system parameters as predictors of dry eye symptoms after LASIK","volume":"19","author":"Levitt","year":"2021","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.biopha.2021.112505_bib23","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1167\/iovs.04-0299","article-title":"Stimulation of matrix metalloproteinases by hyperosmolarity via a JNK pathway in human corneal epithelial cells","volume":"45","author":"Li","year":"2004","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2021.112505_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.biopha.2021.112505_bib25","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1124\/jpet.102.041574","article-title":"Injury type-specific calcium channel alpha 2 delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin","volume":"303","author":"Luo","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2021.112505_bib26","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/01.STR.0000125719.25853.20","article-title":"Pooling of animal experimental data reveals influence of study design and publication bias","volume":"35","author":"Macleod","year":"2004","journal-title":"Stroke"},{"issue":"Suppl. 1","key":"10.1016\/j.biopha.2021.112505_bib27","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/j.pain.0000000000000428","article-title":"The endocannabinoid system and neuropathic pain","volume":"157","author":"Maldonado","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2021.112505_bib28","doi-asserted-by":"crossref","first-page":"e753","DOI":"10.1111\/aos.14657","article-title":"Phantom eye pain: a multicentric study in 100 patients","volume":"99","author":"Martel","year":"2021","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.biopha.2021.112505_bib29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.preteyeres.2018.11.005","article-title":"Corneal pain and experimental model development","volume":"71","author":"McKay","year":"2019","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.biopha.2021.112505_bib30","doi-asserted-by":"crossref","first-page":"17225","DOI":"10.1038\/s41598-020-73945-w","article-title":"acrimal gland excision in male and female mice causes ocular pain and anxiety-like behaviors","volume":"10","author":"Mecum","year":"2020","journal-title":"Sci. Rep."},{"issue":"13","key":"10.1016\/j.biopha.2021.112505_bib31","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1080\/09205063.2021.1932359","article-title":"Formulation development, optimization, and in vitro assessment of thermoresponsive ophthalmic pluronic F127-chitosan in situ tacrolimus gel","volume":"32","author":"Modi","year":"2021","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.biopha.2021.112505_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.biopha.2021.112505_bib33","doi-asserted-by":"crossref","first-page":"987","DOI":"10.2174\/1871527315666160413123621","article-title":"Chalcone derivatives activate and desensitize the transient receptor potential ankyrin 1 cation channel, subfamily A, member 1 TRPA1 ion channel: structure-activity relationships in vitro and anti-nociceptive and anti-inflammatory activity in vivo","volume":"15","author":"Moriello","year":"2016","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.biopha.2021.112505_bib34","series-title":"Ocular Neuropathic Pain, StatPearls. StatPearls Publishing Copyright \u00a9 2021","author":"Moshirfar","year":"2021"},{"key":"10.1016\/j.biopha.2021.112505_bib35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/bs.pbr.2015.04.010","article-title":"Links among glaucoma, neurodegenerative, and vascular diseases of the central nervous system","volume":"221","author":"Nucci","year":"2015","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.biopha.2021.112505_bib36","doi-asserted-by":"crossref","first-page":"S209","DOI":"10.21037\/apm.2017.08.04","article-title":"Modulating the endocannabinoid pathway as treatment for peripheral neuropathic pain: a selected review of preclinical studies","volume":"6","author":"O\u2019Hearn","year":"2017","journal-title":"Ann. Palliat. Med."},{"key":"10.1016\/j.biopha.2021.112505_bib37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pnpbp.2016.01.007","article-title":"Effect of JWH-250, JWH-073 and their interaction on \u201ctetrad\u201d, sensorimotor, neurological and neurochemical responses in mice","volume":"67","author":"Ossato","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2021.112505_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24183338","article-title":"Selective cannabinoid 2 receptor agonists as potential therapeutic drugs for the treatment of endotoxin-induced uveitis","volume":"24","author":"Porter","year":"2019","journal-title":"Molecules"},{"issue":"3 Suppl.","key":"10.1016\/j.biopha.2021.112505_bib39","first-page":"S102","article-title":"Prevalence, burden, and pharmacoeconomics of dry eye disease","volume":"14","author":"Pflugfelder","year":"2008","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.biopha.2021.112505_bib40","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.sjpain.2013.02.002","article-title":"Transparency in the reporting of in vivo pre-clinical pain research: the relevance and implications of the ARRIVE (Animal Research: Reporting In Vivo Experiments) guidelines","volume":"4","author":"Rice","year":"2013","journal-title":"Scand. J. Pain"},{"issue":"8","key":"10.1016\/j.biopha.2021.112505_bib41","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11910-018-0859-x","article-title":"Cannabinoids for treatment of MS symptoms: state of the evidence","volume":"18","author":"Rice","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.biopha.2021.112505_bib42","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2156873","article-title":"Anxiolytic-like effects of bergamot essential oil are insensitive to flumazenil in rats","volume":"2019","author":"Rombol\u00e0","year":"2019","journal-title":"Evid.-Based Complement. Altern. Med.: eCAM"},{"key":"10.1016\/j.biopha.2021.112505_bib43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/ijms21072597","article-title":"Role of 5-HT1A receptor in the anxiolytic-relaxant effects of bergamot essential oil in rodent","volume":"21","author":"Rombol\u00e0","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2021.112505_bib44","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/bjophthalmol-2014-306280","article-title":"Ocular neuropathic pain","volume":"100","author":"Rosenthal","year":"2016","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.biopha.2021.112505_bib45","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/s41419-018-1044-5","article-title":"Rapamycin and fasting sustain autophagy response activated by ischemia\/reperfusion injury and promote retinal ganglion cell survival","volume":"9","author":"Russo","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2021.112505_bib46","unstructured":"Ryan, R., Cochrane Consumers and Communication Review Group: data synthesis and analysis, 2019. Available at: \u3008http:\/\/cccrg.cochrane.org\u3009, (Accessed 13 March 2019)."},{"key":"10.1016\/j.biopha.2021.112505_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13030379","article-title":"Development and translation of NanoBEO, a nanotechnology-based delivery system of bergamot essential oil deprived of furocumarins, in the control of agitation in severe dementia","volume":"13","author":"Scuteri","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2021.112505_bib48","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.fitote.2018.06.007","article-title":"Antinociceptive effect of inhalation of the essential oil of bergamot in mice","volume":"129","author":"Scuteri","year":"2018","journal-title":"Fitoterapia"},{"key":"10.1016\/j.biopha.2021.112505_bib49","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.4103\/1673-5374.237125","article-title":"Evidence for accuracy of pain assessment and painkillers utilization in neuropsychiatric symptoms of dementia in Calabria region, Italy","volume":"13","author":"Scuteri","year":"2018","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.biopha.2021.112505_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.640128","article-title":"Efficacy of essential oils in pain: a systematic review and meta-analysis of preclinical evidence","volume":"12","author":"Scuteri","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2021.112505_bib51","doi-asserted-by":"crossref","first-page":"890","DOI":"10.3389\/fneur.2020.00890","article-title":"Pain assessment and treatment in dementia at the time of coronavirus disease COVID-19","volume":"11","author":"Scuteri","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.biopha.2021.112505_bib52","doi-asserted-by":"crossref","first-page":"229","DOI":"10.11138\/FNeur\/2017.32.4.229","article-title":"The need for better access to pain treatment: learning from drug consumption trends in the USA","volume":"22","author":"Scuteri","year":"2017","journal-title":"Funct. Neurol."},{"key":"10.1016\/j.biopha.2021.112505_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20133327","article-title":"Neuropharmacology of the neuropsychiatric symptoms of dementia and role of pain: essential oil of bergamot as a novel therapeutic approach","volume":"20","author":"Scuteri","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2021.112505_bib54","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.2174\/0929867325666180307115546","article-title":"Neuropharmacological properties of the essential oil of bergamot for the clinical management of pain-related BPSDs","volume":"26","author":"Scuteri","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.biopha.2021.112505_bib55","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.1002\/ptr.7223","volume":"35","author":"Scuteri","year":"2021","journal-title":"Phytother. Res.: PTR"},{"key":"10.1016\/j.biopha.2021.112505_bib56","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00228-020-02995-w","article-title":"Pattern of treatment of behavioural and psychological symptoms of dementia and pain: evidence on pharmacoutilization from a large real-world sample and from a centre for cognitive disturbances and dementia","volume":"77","author":"Scuteri","year":"2021","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2021.112505_bib57","unstructured":"Seyed-Razavi Y., Lopez M.J., Yamaguchi T., Hamrah P., A novel experimental model for corneal neuropathic pain: the ciliary nerve ligation approach. Investig. Ophthalmol. Vis. Sci., vol. 58, pp. 3951\u20133951. ARVO Annual Meeting Abstract, 2017."},{"issue":"3","key":"10.1016\/j.biopha.2021.112505_bib58","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4103\/0974-620X.169910","article-title":"Prevalence and associated factors of dry eye: our experience in patients above 40 years of age at a Tertiary Care Center","volume":"8","author":"Shah","year":"2015","journal-title":"Oman J. Ophthalmol."},{"key":"10.1016\/j.biopha.2021.112505_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2020.104907","article-title":"Effect of acute and subchronic administration of (R)-WIN55,212-2 induced neuroprotection and anti inflammatory actions in rat retina: CB1 and CB2 receptor involvement","volume":"142","author":"Spyridakos","year":"2021","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.biopha.2021.112505_bib60","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0014-2999(01)01438-8","article-title":"Cannabinoid CB(1) receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues","volume":"431","author":"Stamer","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2021.112505_bib61","first-page":"2442","article-title":"Localization of cannabinoid CB1 receptors in the human anterior eye and retina","volume":"40","author":"Straiker","year":"1999","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2021.112505_bib62","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.neuroscience.2010.04.034","article-title":"Behavioral and neurophysiological correlates of nociception in an animal model of photokeratitis","volume":"169","author":"Tashiro","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2021.112505_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25020417","article-title":"Allosteric cannabinoid receptor 1 (CB1) ligands reduce ocular pain and inflammation","volume":"25","author":"Thapa","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2021.112505_bib64","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/can.2017.0041","article-title":"The cannabinoids \u0394(8)THC, CBD, and HU-308 act via distinct receptors to reduce corneal pain and inflammation","volume":"3","author":"Thapa","year":"2018","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.biopha.2021.112505_bib65","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1167\/iovs.61.10.48","article-title":"THC regulates tearing via cannabinoid CB1 receptors","volume":"61","author":"Thayer","year":"2020","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2021.112505_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2016.00304","article-title":"Turning down the thermostat: modulating the endocannabinoid system in ocular inflammation and pain","volume":"7","author":"Toguri","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2021.112505_bib67","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/bph.12545","article-title":"Anti-inflammatory effects of cannabinoid CB(2) receptor activation in endotoxin-induced uveitis","volume":"171","author":"Toguri","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2021.112505_bib68","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.prostaglandins.2018.09.004","article-title":"Inflammation and CB(2) signaling drive novel changes in the ocular lipidome and regulate immune cell activity in the eye","volume":"139","author":"Toguri","year":"2018","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.biopha.2021.112505_bib69","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3233\/CH-151996","article-title":"Cannabinoid 2 receptor activation reduces leukocyte adhesion and improves capillary perfusion in the iridial microvasculature during systemic inflammation","volume":"61","author":"Toguri","year":"2015","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"10.1016\/j.biopha.2021.112505_bib70","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1590\/1806-9282.20200888","article-title":"Depression and dry eye: a narrative review","volume":"67","author":"Vieira","year":"2021","journal-title":"Rev. Assoc. Med. Bras."},{"key":"10.1016\/j.biopha.2021.112505_bib71","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3389\/fphar.2018.01259","article-title":"Cannabinoids and pain: new insights from old molecules","volume":"9","author":"Vu\u010dkovi\u0107","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2021.112505_bib72","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1097\/ICO.0000000000001336","article-title":"Alkali burn induced corneal spontaneous pain and activated neuropathic pain matrix in the central nervous system in mice","volume":"36","author":"Xiang","year":"2017","journal-title":"Cornea"},{"key":"10.1016\/j.biopha.2021.112505_bib73","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1189\/jlb.0307159","article-title":"Anti-inflammatory property of the cannabinoid receptor-2-selective agonist JWH-133 in a rodent model of autoimmune uveoretinitis","volume":"82","author":"Xu","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.biopha.2021.112505_bib74","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.cellsig.2012.10.015","article-title":"Cannabinoid receptor 1 suppresses transient receptor potential vanilloid 1-induced inflammatory responses to corneal injury","volume":"25","author":"Yang","year":"2013","journal-title":"Cell. Signal."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221012919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221012919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T10:49:22Z","timestamp":1779965362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221012919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":74,"alternative-id":["S0753332221012919"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112505","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is there a rational basis for cannabinoids research and development in ocular pain therapy? A systematic review of preclinical evidence","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112505","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112505"}}